From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Beaufort on MySquar - is this the worst broker note of the year?

By Tom Winnifrith, The Sheriff of AIM | Wednesday 11 October 2017


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Clearly no-one told Belfort Securities that its star client in the fraud sector, MySquar (MYSQ) was going to have a disastrous lack of profits warning today which exposed how it had massively misled investors for months. Because yesterday it urged its clients to fill their boots at 4.02p with a 21p target. At least this shows that at Belfort the Chinese walls between research and broking have no chinks in them. The shares are now 2.98p and are worth 0p. Over to Belfort.... 


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 11:46:19